Review article: Helicobacter pylori-negative duodenal ulcer disease

Aliment Pharmacol Ther. 2009 Oct 15;30(8):791-815. doi: 10.1111/j.1365-2036.2009.04105.x. Epub 2008 Jul 23.

Abstract

Background: Helicobacter pylori infection rates in duodenal ulcer (DU) patients may be lower than previously estimated.

Aim: To review the real prevalence of H. pylori-negative DUs and its possible causes.

Methods: Bibliographical searches in MEDLINE looking for the terms 'H. pylori' and 'duodenal ulcer'.

Results: Mean prevalence of H. pylori infection in DU disease, calculated from studies published during the last 10 years including a total of 16 080 patients, was 81%, and this figure was lower (77%) when only the last 5 years were considered. Associations with H. pylori-negative DU were: (1) False negative results of diagnostic methods, (2) NSAID use (21% in studies with <90% infection rate), (3) Complicated DU (bleeding, obstruction, perforation), (4) Smoking, (5) Isolated H. pylori duodenal colonization, (6) Older age, (7) Gastric hypersecretion, (8) Diseases of the duodenal mucosa, (9) Helicobacter'heilmanii' infection and (10) Concomitant diseases.

Conclusion: In patients with H. pylori-negative DU disease, one should carefully confirm that the assessment of H. pylori status is reliable. In truly H. pylori-negative patients, the most common single cause of DU is, by far, the use of NSAIDs. Ulcers not associated with H. pylori, NSAIDs or other obvious causes should, for the present, be viewed as 'idiopathic'. True idiopathic DU disease only exceptionally exists.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Duodenal Ulcer / drug therapy
  • Duodenal Ulcer / epidemiology
  • Duodenal Ulcer / etiology*
  • Epidemiologic Methods
  • False Negative Reactions
  • Helicobacter Infections / complications*
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / epidemiology
  • Helicobacter pylori
  • Humans
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Proton Pump Inhibitors